4/18
02:03 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Medium
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
4/16
02:14 pm
apvo
Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why [Yahoo! Finance]
Low
Report
Aptevo (APVO) Stock Plummets 79% in a Week: Here's Why [Yahoo! Finance]
4/15
04:23 pm
apvo
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering [Yahoo! Finance]
Low
Report
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering [Yahoo! Finance]
4/15
04:05 pm
apvo
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering
Low
Report
Aptevo Therapeutics Announces Closing of $4.6 Million Public Offering
4/10
09:15 am
apvo
Aptevo Therapeutics Provides Pipeline Update [Yahoo! Finance]
High
Report
Aptevo Therapeutics Provides Pipeline Update [Yahoo! Finance]
4/10
09:00 am
apvo
Aptevo Therapeutics Provides Pipeline Update
High
Report
Aptevo Therapeutics Provides Pipeline Update
4/10
02:03 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
High
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
4/2
02:05 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/25
02:06 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
High
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/18
06:16 am
apvo
Aptevo Participating in The Springtime Partnering Event, a Bio-Europe Conference [Yahoo! Finance]
Medium
Report
Aptevo Participating in The Springtime Partnering Event, a Bio-Europe Conference [Yahoo! Finance]
3/18
06:00 am
apvo
Aptevo Participating in The Springtime Partnering Event, a Bio-Europe Conference
Medium
Report
Aptevo Participating in The Springtime Partnering Event, a Bio-Europe Conference
3/17
02:03 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/9
02:09 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
High
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
3/7
09:16 am
apvo
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4 [Yahoo! Finance]
High
Report
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4 [Yahoo! Finance]
3/7
08:55 am
apvo
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4
Low
Report
Alligator Bioscience and Aptevo Therapeutics Announce Positive Interim Data of Dose Escalation Phase of ALG.APV-527 Phase 1 Study in Solid Tumor Cancers Expressing Tumor Antigen 5T4
3/5
08:23 am
apvo
Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update [Yahoo! Finance]
Medium
Report
Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update [Yahoo! Finance]
3/5
08:05 am
apvo
Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update
Medium
Report
Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update
3/4
09:09 am
apvo
Aptevo Therapeutics Announces 1-for 44 Reverse Stock Split As Part of Nasdaq Compliance Plan [Yahoo! Finance]
Medium
Report
Aptevo Therapeutics Announces 1-for 44 Reverse Stock Split As Part of Nasdaq Compliance Plan [Yahoo! Finance]
3/4
09:00 am
apvo
Aptevo Therapeutics Announces 1-for 44 Reverse Stock Split As Part of Nasdaq Compliance Plan
Medium
Report
Aptevo Therapeutics Announces 1-for 44 Reverse Stock Split As Part of Nasdaq Compliance Plan
3/1
02:04 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
2/22
02:04 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
2/14
01:10 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Medium
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
2/6
01:09 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
1/29
01:06 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
1/21
01:06 am
apvo
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.
Low
Report
Aptevo Therapeutics Inc. (NASDAQ: APVO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.